Pattern of axonal injury in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis: Implications for multiple sclerosis
Introduction
Multiple sclerosis (MS) is an inflammatory demyelinating disease of the central nervous system (CNS). Although morphological changes of axons like transsections and formation of spheroids have long been recognized in MS lesions (Kornek and Lassmann, 1999), the importance of axonal damage was only recently revived and refined with the avenue of new imaging techniques like confocal laser scanning microscopy (Trapp et al., 1998) or magnetic resonance spectroscopy (Narayanan et al., 1997). While histopathologic staining for amyloid precursor protein (APP) as a marker revealed that acute axonal injury in MS is already extensive early (Bitsch et al., 2000, Kuhlmann et al., 2002), imaging studies also point at a critical role of axonal loss for disease progression and accumulation of disability at later time points of the disease (De Stefano et al., 1998, De Stefano et al., 2001).
In rat models, patterns of axonal damage and in some settings also neuronal injury are characterized in experimental autoimmune encephalomyelitis (EAE) after immunization with myelin oligodendrocyte glycoprotein (MOG) mimicking many aspects of MS (Hobom et al., 2004, Storch et al., 1998). After immunization with recombinant MOG, axonal damage was observed in the white matter of marmoset monkeys (Boretius et al., 2006) and rodents (Kornek et al., 2000) and in focal EAE models also in the cortex of susceptible rat strains (Merkler et al., 2006). Investigation of axonal damage in chronic rat EAE and murine relapsing remitting proteolipoprotein (PLP) induced EAE underscored the concept that axonal loss may in particular correlate with permanent disability (Papadopoulos et al., 2006, Wujek et al., 2002). In murine MOG-EAE induced by the encephalitogenic peptide 35–55 (MOG 35–55 EAE), axonal injury was mainly investigated in genetic models. Mice with a deficiency of the axonoprotective neurotrophic cytokine ciliary neurotrophic factor (CNTF) exhibit a more severe course of MOG-EAE with enhanced myelin and axonal pathology (Linker et al., 2002). In a Thy1-GFP transgenic mouse model, patterns of axonal damage could be directly characterized by fluorescent labeling of axon tracts in the spinal cord (Bannerman et al., 2005).
Yet, EAE models do not only allow investigation of axonal injury, but also recovery and axonoprotection (Diem et al., 2007). In a focal EAE model in rats, remodelling of axonal connections could be elegantly investigated (Kerschensteiner et al., 2004). Recent studies focused on the role of the wlds fusion protein as an endogenous axonal protection mechanism in murine MOG-EAE (Kaneko et al., 2006, Tsunoda et al., 2007) while some earlier studies in rodents characterized neuroprotective treatment approaches like blocking of glutamate receptors (Pitt et al., 2000).
Different mechanisms contribute to axonal damage during autoimmune demyelination (for overview see Neumann (2003)). Among others, candidates include TNF-alpha mediated cytotoxicity, Fas–FasL interaction or glutamate excitotoxicity (Werner et al., 2001). Moreover, interaction of cytotoxic CD8 positive T cells with upregulated MHC-I on axons may play a role (Medana et al., 2001) although mice lacking MHC-I exhibit significant amounts of APP positive axons (Linker et al., 2005). In a murine EAE model, an altered expression of sodium channels was shown in the optic nerve (Craner et al., 2003b). At sites of axonal injury, this re-expression and re-distribution of sodium channels correlated with APP expression as a marker of axonal damage and expression of a sodium–calcium exchanger (Craner et al., 2004). Indeed, blocking of sodium channels may provide an attractive new therapeutic approach for autoimmune demyelination (Bechtold et al., 2004, Bechtold et al., 2006, Black et al., 2006). Recently, the expression of sodium channels in MS and EAE lesions was also implicated in remyelination (Coman et al., 2006). Yet, altered expression of sodium channels may also be detrimental: Changes in intracellular sodium could lead to reverse action of a sodium–calcium exchanger thus resulting in calcium overload and subsequent destruction of the axonal cytoskeleton (for review see Stys (2005)). The importance of calcium for axonal degeneration is further underscored by a study revealing expression of calcium channel subunits in dystrophic axons (Kornek et al., 2001).
Despite all these investigations, a comprehensive analysis including different markers of axonal damage in MOG-EAE of C57BL/6 mice has not been undertaken so far, although the model is of particular interest in view of the many genetically engineered strains on this background. Here we investigate axonal injury over the course of MOG-EAE in C57BL/6 mice including quantification of axonal loss, APP expression, neurofilament phosphorylation and distribution of sodium channels. Our data reveal distinct patterns of axonal pathology early and late during MOG-EAE.
Section snippets
Animals
C57BL/6 mice were purchased from Harlan (Borchen, Germany) and bred at the in-house animal care facilities of the Institute for MS Research, University of Göttingen, Germany. All animal experiments were performed in accordance with the Lower Saxony State regulations for animal welfare.
Induction and clinical evaluation of active MOG-EAE
For active induction of EAE, a total of 22 mice received a s.c. injection at flanks and tail base of 200 µg MOG 35–55 peptide (Charité, Berlin, Germany) in PBS emulsified in an equal volume of CFA containing
Clinical course and pattern of inflammation in murine MOG-EAE
After onset of disease shortly before day 10 p.i. and the first maximum around day 13 p.i., mice display persistent disability over time remaining unchanged upon observation until day 60 p.i. (Table 1). To investigate inflammation, sections were stained with the anti F4/80 antibody to label macrophages and microglia and an anti-CD4 or anti-CD8 antibody to label CD4 positive or CD8 positive T cells. Both numbers of macrophages and microglia as well as CD4 positive T cells peaked at the maximum
Discussion
In the present study we investigate time course and pattern of axonal injury in murine MOG-EAE in C57BL/6 mice. First, we show that axonal loss in lesions, but also in grey matter occurs very early and does not recover over time. Well in line with the observation of early axonal injury in animal models (Wang et al., 2005) human studies investigating the extent of acute axonal damage in MS lesions by APP immunohistochemistry also revealed extensive damage already at early disease stages (
Acknowledgments
This work was supported by the Gemeinnützige Hertie-Stiftung (project 1.01.1/05/009), the Max-Planck-Society and the Deutsche Forschungsgemeinschaft (through SFB 406). The skillful technical assistance of Silvia Seubert and Alexandra Bohl is gratefully acknowledged. We thank Profs. W. Stühmer and C. Stadelmann for the advice and stimulating discussions.
References (52)
- et al.
Axonal loss in the pathology of MS: consequences for understanding the progressive phase of the disease
J. Neurol. Sci.
(2003) - et al.
Sodium channel mRNAs in cultured spinal cord astrocytes: in situ hybridization in identified cell types
Brain Res. Mol. Brain Res.
(1994) - et al.
Neurodegeneration and –protection in autoimmune CNS inflammation
J. Neuroimmunol.
(2007) - et al.
Re-expression of a developmentally restricted potassium channel in autoimmune demyelination: Kv1.4 is implicated in oligodendroglial proliferation
Am. J. Pathol.
(2007) - et al.
Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions
Am. J. Pathol.
(2000) - et al.
EAE in beta-2 microglobulin-deficient mice: axonal damage is not dependent on MHC-I restricted immune responses
Neurobiol. Dis.
(2005) - et al.
Transection of major histocompatibility complex class I-induced neurites by cytotoxic T lymphocytes
Am. J. Pathol.
(2001) - et al.
Axon loss is responsible for chronic neurological deficit following inflammatory demyelination in the rat
Exp. Neurol.
(2006) General mechanisms of axonal damage and its prevention
J. Neurol. Sci.
(2005)- et al.
Contrasting roles for axonal degeneration in an autoimmune versus viral model of multiple sclerosis: when can axonal injury be beneficial?
Am. J. Pathol.
(2007)
Altered expression of ion channel isoforms at the node of Ranvier in P0-deficient myelin mutants
Mol. Cell Neurosci.
Motor neuron pathology in experimental autoimmune encephalomyelitis: studies in THY1-YFP transgenic mice
Brain
Axonal protection using flecainide in experimental autoimmune encephalomyelitis
Ann. Neurol.
Axonal protection achieved in a model of multiple sclerosis using lamotrigine
J. Neurol.
Acute axonal injury in multiple sclerosis. Correlation with demyelination and inflammation
Brain
Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences
Curr. Opin. Neurol.
Long-term protection of central axons with phenytoin in monophasic and chronic-relapsing EAE
Brain
Sodium channel expression within chronic multiple sclerosis plaques
J. Neuropathol. Exp. Neurol.
Monitoring of EAE onset and progression in the common marmoset monkey by sequential high-resolution 3D MRI
NMR Biomed.
Nodal, paranodal and juxtaparanodal axonal proteins during demyelination and remyelination in multiple sclerosis
Brain
Temporal course of upregulation of Na(v)1.8 in Purkinje neurons parallels the progression of clinical deficit in experimental allergic encephalomyelitis
J. Neuropathol. Exp. Neurol.
Abnormal sodium channel distribution in optic nerve axons in a model of inflammatory demyelination
Brain
Co-localization of sodium channel Nav1.6 and the sodium–calcium exchanger at sites of axonal injury in the spinal cord in EAE
Brain
Sodium channels contribute to microglia/macrophage activation and function in EAE and MS
Glia
Axonal regeneration in old multiple sclerosis plaques. Immunohistochemical study with monoclonal antibodies to phosphorylated and non-phosphorylated neurofilament proteins
Acta Neuropathol. (Berl)
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
Brain
Cited by (0)
- 1
Present address: Pharmazentrum, University of Basel, Klingelbergstrasse 50/70, CH-4056 Basle, Switzerland.